Stay updated on ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page.

Latest updates to the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page
- Check4 days agoChange DetectedResults for the ABBV-8E12 early Alzheimer's disease study have been posted. The study record dates were updated, with the Results First Posted date now listed as 2022-08-26 and the latest update posted on 2022-08-26.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference1%

- Check40 days agoChange DetectedAdded Pick Disease of the Brain and revision v3.1.0; removed multiple drug safety and disease topics and older v3.0.2, signaling a scope update and new versioning.SummaryDifference0.4%

- Check47 days agoChange DetectedNo significant changes detected.SummaryDifference0.2%

- Check54 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page.